The traditional developer assumption of one engineer per AI agent is being challenged by the concept of massive, collaborative multi-agent systems. James Zou of Stanford University presented research demonstrating the potential of tens of thousands of specialized AI agents working together. His team developed a practical blueprint for connecting legacy data systems to AI orchestration layers, enabling this collaboration. They began by creating a "Virtual Lab" that mirrored Zou's physical research team, successfully designing novel nanobody proteins. This led to the ambitious "Virtual Biotech" project, featuring tens of thousands of agents organized into divisions like target discovery and molecule design. A key advantage of multi-agent systems, as shown in head-to-head comparisons, is their ability to produce more creative and robust solutions through simulated debate and disagreement. Orchestrating such large systems presents a bottleneck, particularly in integrating legacy data. Zou's team addressed this with Paperclip, a platform that digitizes unstructured data and maps databases into a unified, AI-native virtual file system. This infrastructure significantly improves accuracy and reduces time and cost compared to traditional methods. Real-world validation included Virtual Biotech agents identifying clinical trial success predictors and autonomously designing a therapeutic that Merck later independently validated and received FDA breakthrough designation for. Zou advocates for designing collaborative environments rather than rigid workflows, focusing on optimizing the overall system rather than individual agents. This shift in perspective is crucial for scaling multi-agent systems effectively.